Novo Nordisk share in historic slump – Weight loss trial disappoints
The trial participants achieved an average of 22.7 percent weight loss over a period of 68 weeks, Novo writes in a company announcement.This is less than what investors hoped and expected. The share fell by 27 percent for a period, and ended 20 percent down at the end of trading.The stock market had expected a […]
Full version of this article is only available to subscribers.
Already a subscriber, sign in here:
Gain unlimited access to all of The Copenhagen Post
Our independent reporting can only be published with support from our readers.
Monthly subscription
119
DKK/month.
(Billed once a month)
Give us a try
6 month subscription
99
DKK/month.
(Billed twice a year)
Yearly subscription
79
DKK/month.
(Billed once a year)
The post Novo Nordisk share in historic slump – Weight loss trial disappoints appeared first on The Copenhagen Post.